May 20, 2006
FDA Approves Cervical Cancer Vaccine
A vaccine that protects against the virus known to cause most cervical cancers was given the blessing of a U.S. Food and Drug Administration advisory panel Thursday.
The vaccine, Gardasil, is expected to get full FDA approval on June 8, and the national Advisory Committee on Immunization Practices will then decide whether to include the vaccine in routine vaccination schedules. Gardasil, which is manufactured by Merck & Co., would then become the first vaccine to be approved for the prevention of cervical cancer. (excite.com)
